Jason C. Gallagher, PharmD

Clinical Professor
Temple University School of Pharmacy

Disclosure: Allergan (Individual(s) Involved: Self): Consultant; Astellas (Individual(s) Involved: Self): Consultant; Merck (Individual(s) Involved: Self): Consultant; Nabriva (Individual(s) Involved: Self): Consultant; Qpex (Individual(s) Involved: Self): Consultant; scPharmaceuticals (Individual(s) Involved: Self): Consultant; Shionogi (Individual(s) Involved: Self): Consultant; Spero (Individual(s) Involved: Self): Consultant; Tetraphase (Individual(s) Involved: Self): Consultant

Presentation(s):

• 158 - Intra- and Inter-hospital Epidemiology of Carbapenem-resistant klebsiella Pneumoniae in US Hospitals

  Oral Abstract